Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:FPXNASDAQ:KODNYSE:NIM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFPXFirst Trust US Equity Opportunities ETF$125.52+4.1%$113.06$88.74▼$143.53$815.88M1.2421,776 shs19,954 shsKODKodiak Sciences$4.80+6.9%$3.27$1.92▼$11.60$253.21M2.4344,350 shs615,630 shsNIMNuveen Select Maturities Municipal Fund$9.21-1.3%$9.17$8.60▼$9.64$114.64M0.2233,122 shs42,401 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFPXFirst Trust US Equity Opportunities ETF+4.15%+6.80%+8.58%-4.49%+27.17%KODKodiak Sciences+6.90%+16.79%+79.78%-25.00%+35.98%NIMNuveen Select Maturities Municipal Fund-1.23%-1.71%-0.86%+2.33%+4.13%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFPXFirst Trust US Equity Opportunities ETFN/AN/AN/AN/AN/AN/AN/AN/AKODKodiak Sciences4.0359 of 5 stars3.01.00.04.63.43.30.6NIMNuveen Select Maturities Municipal FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFPXFirst Trust US Equity Opportunities ETF 2.60Moderate Buy$125.52N/AKODKodiak Sciences 2.00Hold$9.0087.50% UpsideNIMNuveen Select Maturities Municipal Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest JRV, NIM, KOD, and FPX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/31/2025KODKodiak SciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.00(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFPXFirst Trust US Equity Opportunities ETFN/AN/AN/AN/AN/AN/AKODKodiak SciencesN/AN/AN/AN/A$5.07 per shareN/ANIMNuveen Select Maturities Municipal Fund$10.65M10.76N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFPXFirst Trust US Equity Opportunities ETFN/AN/A28.17∞N/AN/AN/AN/AN/AKODKodiak Sciences-$260.49M-$3.36N/AN/AN/AN/A-84.52%-45.40%5/13/2025 (Estimated)NIMNuveen Select Maturities Municipal FundN/AN/A0.00∞N/AN/AN/AN/A6/2/2025 (Estimated)Latest JRV, NIM, KOD, and FPX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025KODKodiak Sciences-$0.89N/AN/AN/AN/AN/A3/27/2025Q4 2024KODKodiak Sciences-$0.90-$0.84+$0.06-$0.84N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFPXFirst Trust US Equity Opportunities ETF$0.110.09%N/AN/AN/AKODKodiak SciencesN/AN/AN/AN/AN/ANIMNuveen Select Maturities Municipal Fund$0.363.91%+8.49%N/AN/ALatest JRV, NIM, KOD, and FPX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/2/2025NIMNuveen Select Maturities Municipal Fundmonthly$0.02753.6%5/15/20255/15/20256/2/20254/3/2025NIMNuveen Select Maturities Municipal Fundmonthly$0.02753.6%4/15/20254/15/20255/1/20253/3/2025NIMNuveen Select Maturities Municipal FundMonthly$0.02753.61%3/14/20253/14/20254/1/20252/3/2025NIMNuveen Select Maturities Municipal FundMonthly$0.02753.65%2/14/20252/14/20253/3/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFPXFirst Trust US Equity Opportunities ETFN/AN/AN/AKODKodiak SciencesN/A8.428.42NIMNuveen Select Maturities Municipal FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFPXFirst Trust US Equity Opportunities ETFN/AKODKodiak Sciences89.06%NIMNuveen Select Maturities Municipal Fund32.23%Insider OwnershipCompanyInsider OwnershipFPXFirst Trust US Equity Opportunities ETFN/AKODKodiak Sciences45.30%NIMNuveen Select Maturities Municipal FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFPXFirst Trust US Equity Opportunities ETFN/A6.50 millionN/ANot OptionableKODKodiak Sciences9052.75 million28.79 millionOptionableNIMNuveen Select Maturities Municipal FundN/A12.45 millionN/ANot OptionableJRV, NIM, KOD, and FPX HeadlinesRecent News About These CompaniesMuni Update: Technicals Push Tax-Exempt Bonds LowerApril 23, 2025 | seekingalpha.comFed Keeps Rates Steady, Ups Inflation Target: How are Banks Affected?March 20, 2025 | zacks.comNuveen Select Maturities Municipal Fund declares $0.0275 dividendMarch 4, 2025 | seekingalpha.com1607 Capital Partners, LLC Expands Stake in Nuveen Select Maturities Municipal FundFebruary 13, 2025 | gurufocus.com(NIM) Technical Pivots with Risk ControlsDecember 26, 2024 | news.stocktradersdaily.com(NIM) Trading AdviceDecember 16, 2024 | news.stocktradersdaily.comNuveen Select Maturities Municipal Fund raises monthly dividend by 26.5% to $0.0348/shareDecember 3, 2024 | seekingalpha.comNuveen Select Maturities Municipal Fund Declares Capital Gain DistributionDecember 2, 2024 | investing.com(NIM) Long Term Investment AnalysisNovember 15, 2024 | news.stocktradersdaily.comWhen (NIM) Moves Investors should ListenSeptember 21, 2024 | news.stocktradersdaily.comActive Management Will Drive Muni Returns In 2024September 15, 2024 | seekingalpha.comNuveen Select Maturities Municipal Fund Share ChatSeptember 4, 2024 | lse.co.ukHow to Take Advantage of moves in (NIM)August 26, 2024 | news.stocktradersdaily.com(NIM) Trading SignalsAugust 2, 2024 | news.stocktradersdaily.comNuveen Select Maturities MuniJuly 26, 2024 | morningstar.comNuveen Michigan Municipal Bond Fund;IMay 23, 2024 | wsj.comNuveen Minnesota Intermediate Municipal Bond Fund;IApril 26, 2024 | wsj.comNuveen Select Maturities Stock (NYSE:NIM), DividendsFebruary 23, 2024 | benzinga.comINSI Insight Select Income FundDecember 20, 2023 | seekingalpha.comNuveen Ohio Municipal Bond Fund;ANovember 17, 2023 | wsj.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Signs of a more buyer-friendly housing market emerge for the spring homebuying seasonBy The Associated Press | April 6, 2025View Signs of a more buyer-friendly housing market emerge for the spring homebuying season5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeatBoeing: Turbulence Is Minimal Even If China Stops Buying PlanesBy Jea Yu | April 25, 2025View Boeing: Turbulence Is Minimal Even If China Stops Buying PlanesJRV, NIM, KOD, and FPX Company DescriptionsFirst Trust US Equity Opportunities ETF NYSEARCA:FPX$125.52 +5.00 (+4.15%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$126.09 +0.57 (+0.45%) As of 05/2/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.First Trust US IPO Index Fund (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the IPOX-100 U.S. Index (the Index). The Fund will normally invest at least 90% of its assets in common stocks that comprise the Index. The Index is a modified value-weighted price index measuring the performance of the top 100 United States companies ranked quarterly by market capitalization in the IPOX Global Composite Index. The Index utilizes a 10% capping on all constituents and includes the 100 largest, typically best-performing and most liquid initial public offerings (IPOs) of the United States companies in the IPOX Global Composite Index. The IPOX Global Composite Index is reconstituted regularly with IPOs being added to the IPOX Global Composite Index at their seventh trading day upon going public and automatically exiting after 1,000 trading days or approximately four years thereafter. Its investment advisor is First Trust Advisors L.P.Kodiak Sciences NASDAQ:KOD$4.80 +0.31 (+6.90%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$4.75 -0.05 (-1.04%) As of 05/2/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.Nuveen Select Maturities Municipal Fund NYSE:NIM$9.21 -0.12 (-1.29%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$9.24 +0.02 (+0.27%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nuveen Select Maturities Municipal Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund invests primarily in municipal securities rated Baa/BBB or better. It invests in securities that provide income exempt from federal income tax. The fund employs fundamental analysis with bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the S&P Intermediate Municipal Bond Index and the S&P National Municipal Bond Index. Nuveen Select Maturities Municipal Fund was formed on September 18, 1992 and is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/28 - 05/02 Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 Why Spotify Stock Still Has Room to Run in 2025 Is It Time to Load Up on Bond ETFs? Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Roblox Stock Gains Momentum and Can Top $100 in 2025 Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
